|
Volume 272, Number 8,
Issue of February 21, 1997
pp. 4941-4952
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Effect of Extracellular AMP on Cell Proliferation and Metabolism
of Breast Cancer Cell Lines with High and Low Glycolytic Rates
(Received for publication, June 26, 1996, and in revised form, October 15, 1996)
Sybille
Mazurek
,
Andrea
Michel
¶
and
Erich
Eigenbrodt
From the Institut for Biochemistry and Endocrinology,
Veterinary Faculty, Justus-Liebig-University Giessen,
Frankfurter Straße 100, 35392 Giessen and ¶ ScheBo Tech GmbH,
Bahnhofstraße 6, 35435 Wettenberg,
Federal Republic of Germany
In differentiated tissues, such as muscle and
brain, increased adenosine monophosphate (AMP) levels stimulate
glycolytic flux rates. In the breast cancer cell line MCF-7, which
characteristically has a constantly high glycolytic flux rate, AMP
induces a strong inhibition of glycolysis. The human breast cancer cell
line MDA-MB-453, on the other hand, is characterized by a more
differentiated metabolic phenotype. MDA-MB-453 cells have a lower
glycolytic flux rate and higher pyruvate consumption than MCF-7 cells.
In addition, they have an active glycerol 3-phosphate shuttle. AMP
inhibits cell proliferation as well as NAD and NADH synthesis in both
MCF-7 and MDA-MB-453 cells. However, in MDA-MB-453 cells glycolysis is
slightly activated by AMP. This disparate response of glycolytic flux
rate to AMP treatment is presumably caused by the fact that the reduced
NAD and NADH levels in AMP-treated MDA-MB-453 cells reduce lactate
dehydrogenase but not cytosolic glycerol-3-phosphate dehydrogenase
reaction. Due to the different enzymatic complement in MCF-7 cells,
proliferation is inhibited under glucose starvation, whereas MDA-MB-453
cells grow under these conditions. The inhibition of cell proliferation
correlates with a reduction in glycolytic carbon flow to synthetic
processes and a decrease in phosphotyrosine content of several proteins
in both cell lines.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. J. Gillies, I. Robey, and R. A. Gatenby
Causes and Consequences of Increased Glucose Metabolism of Cancers
J. Nucl. Med.,
June 1, 2008;
49(Suppl_2):
24S - 42S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Hathurusinghe, K. S. Goonetilleke, and A. K. Siriwardena
Current Status of Tumor M2 Pyruvate Kinase (Tumor M2-PK) as a Biomarker of Gastrointestinal Malignancy
Ann. Surg. Oncol.,
October 1, 2007;
14(10):
2714 - 2720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Engel, S. Mazurek, E. Eigenbrodt, and C. Welter
Phosphoglycerate Mutase-derived Polypeptide Inhibits Glycolytic Flux and Induces Cell Growth Arrest in Tumor Cell Lines
J. Biol. Chem.,
August 20, 2004;
279(34):
35803 - 35812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-N. Tian, L. D. Braunstein, K. Apse, J. Pang, M. Rose, X. Tian, and R. C. Stanton
Importance of glucose-6-phosphate dehydrogenase activity in cell death
Am J Physiol Cell Physiol,
May 1, 1999;
276(5):
C1121 - C1131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zwerschke, S. Mazurek, P. Massimi, L. Banks, E. Eigenbrodt, and P. Jansen-Durr
Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein
PNAS,
February 16, 1999;
96(4):
1291 - 1296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-N. Tian, L. D. Braunstein, J. Pang, K. M. Stuhlmeier, Q.-C. Xi, X. Tian, and R. C. Stanton
Importance of Glucose-6-phosphate Dehydrogenase Activity for Cell Growth
J. Biol. Chem.,
April 24, 1998;
273(17):
10609 - 10617.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|